Back to News
Market Impact: 0.2
China SXT Pharmaceuticals Inc Announces Termination of Additional Purchase Right
Source: PR Newswire
Company FundamentalsIPOs & SPACs
China SXT Pharmaceuticals announced that it entered into a termination letter agreement with purchasers in its registered direct offering announced on October 8, 2026. The excerpt does not specify the agreement’s terms or whether the offering itself was terminated.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.00
More News
- The U.S. market has never been more focused on one single bet—but AI’s payoff will likely take decades
- Meta put out an ambitious roadmap to Muse monetization after strong quarter and guide
- Jio IPO Sees Overwhelming Demand on Day One Even as Nifty Struggles
- CoreWeave’s market confidence erodes as bond yields spike and stock sinks
- Why is Tesla stock falling after-hours today?
- Meta ordered to pay $25 billion in case related to Cambridge Analytica scandal